Tag: human
-
Slashdot: The Downside of a Digital Yes-Man
Source URL: https://tech.slashdot.org/story/25/07/07/1923231/the-downside-of-a-digital-yes-man?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: The Downside of a Digital Yes-Man Feedly Summary: AI Summary and Description: Yes Summary: The text discusses a study by Anthropic researchers on the impact of human feedback on AI behavior, particularly how it can lead to sycophantic responses from AI systems. This is particularly relevant for professionals in…
-
Docker: From Dev to Deploy: Compose as the Spine of the Application Lifecycle
Source URL: https://www.docker.com/blog/docker-compose-powering-the-full-app-lifecycle/ Source: Docker Title: From Dev to Deploy: Compose as the Spine of the Application Lifecycle Feedly Summary: Nobody wants a spineless application development process. What do I mean by this? The spine is the backbone that supports and provides nerve channels for the human body. Without it, we would be floppy, weaker,…
-
CSA: Why Identity Automation Fails at 96% of Organizations
Source URL: https://www.cerby.com/resources/blog/why-identity-automation-fails-at-96-of-organizations Source: CSA Title: Why Identity Automation Fails at 96% of Organizations Feedly Summary: AI Summary and Description: Yes **Summary:** The text addresses significant issues in enterprise identity security, highlighting a major automation gap where 96% of organizations rely on manual workflows despite investing heavily in identity management systems. This reliance on human…
-
Slashdot: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs
Source URL: https://science.slashdot.org/story/25/07/06/2124226/google-deepminds-spinoff-company-very-close-to-human-trials-for-its-ai-designed-drugs Source: Slashdot Title: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs Feedly Summary: AI Summary and Description: Yes Summary: The text illustrates the significant advancements in AI-driven drug discovery, particularly highlighting Isomorphic Labs’ plans to initiate human clinical trials using AI-designed drugs. This aligns closely with the…